会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • 4,5-DIHYDROIMIDAZOLE DERIVATIVES AND THEIR USE AS HISTONE DEMETHYLASE (KDM2B) INHIBITORS
    • 4,5-DIHYDROIMIDAZOLE衍生物及其用作HISTONE DEMETHYLASE(KDM2B)抑制剂
    • WO2016112251A8
    • 2017-02-02
    • PCT/US2016012588
    • 2016-01-08
    • GENENTECH INCCONSTELLATION PHARMACEUTICALS INC
    • ALBRECHT BRIAN KCOTE ALEXANDREGEHLING VICTORHSIAO-WEI TSUI VICKIEKIEFER JAMES RICHARD JRLIANG JUNMAGNUSON STEVENNASVESCHUK CHRISTOPHER GROMERO F ANTHONYTAYLOR ALEXANDER M
    • C07D403/12A61K31/454A61K31/496A61K31/4995A61P35/00C07D233/44C07D235/02C07D401/04C07D401/12C07D409/12C07D413/12C07D417/12C07D487/08
    • C07D233/44C07D235/02C07D401/04C07D401/12C07D403/12C07D409/12C07D413/12C07D417/12C07D487/08
    • The present invention relates to compounds of formula (I), wherein: X is C(=O) or S(O)2; R1 is selected from the group consisting of N-linked piperazinyl, relinked piperidine, and N-linked diazabicyclo[3.2.1]octane, wherein R1 is optionally substituted with one or more groups; R2 and R3 are each independently selected from H, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, and C3-8cycloalkyl, wherein any C1-6alkyl, C2-6alkenyl, C2-6alkynyl, and C3-8cycloalkyl is optionally substituted with one or more groups; or R2 and R3 taken together with the carbon to which they are attached form a 3-, 4-, 5-, or 6-membered carbocyclic ring that is optionally substituted with one or more groups; R4 and R5 are each independently selected from H, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, and C3-8cycloalkyl, wherein any C1-6alkyl, C2-6alkenyl, C2-6alkynyl, and C3-8cycloalkyl is optionally substituted with one or more groups; or R4 and R5 taken together with the carbon to which they are attached form a 3-, 4-, 5-, or 6-membered carbocyclic ring that is optionally substituted with one or more groups; and R6 is a 5-10 membered heteroaryl, 5-10 membered heterocycle, or a 6-10 membered aryl, which 5-10 membered heteroaryl, 5-10 membered heterocycle, and 6-10 membered aryl is optionally substituted with one or more groups; useful as inhibitors of one or more histone demethylases, such as KDM2b. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using said compositions in the treatment of various disorders.
    • 本发明涉及式(I)化合物,其中:X为C(= O)或S(O)2; R1选自N-连接的哌嗪基,重新连接的哌啶和N-连接的二氮杂双环[3.2.1]辛烷,其中R 1任选被一个或多个基团取代; R 2和R 3各自独立地选自H,C 1-6烷基,C 2-6烯基,C 2-6炔基和C 3-8环烷基,其中任何C 1-6烷基,C 2-6烯基,C 2-6炔基和C 3-8环烷基任选被一个 或更多组; 或者R 2和R 3与它们所连接的碳一起形成任选被一个或多个基团取代的3-,4-,5-或6-元碳环; R 4和R 5各自独立地选自H,C 1-6烷基,C 2-6烯基,C 2-6炔基和C 3-8环烷基,其中任何C 1-6烷基,C 2-6烯基,C 2-6炔基和C 3-8环烷基任选被一个 或更多组; 或者R 4和R 5与它们所连接的碳一起形成任选被一个或多个基团取代的3-,4-,5-或6-元碳环; 并且R 6是5-10元杂芳基,5-10元杂环或6-10元芳基,其中5-10元杂芳基,5-10元杂环和6-10元芳基任选地被一个或多个 组; 可用作一种或多种组蛋白脱甲基酶(例如KDM2b)的抑制剂。 本发明还提供包含本发明化合物的药学上可接受的组合物和使用所述组合物治疗各种疾病的方法。